Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

220
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
220
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

260
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
260
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

494
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
494
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

572
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
572
Cross-reactivity00:42

Cross-reactivity

31.6K
Overview
31.6K
Cancer Vaccines01:30

Cancer Vaccines

544
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
544

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive Analysis of the TLP Gene Family in Pine and Functional Implications in Response to Pine Wood Nematode Infection.

Biology·2026
Same author

Insect Odorant Receptors: From Structure and Evolution to Mechanism and Application.

Insects·2026
Same author

Combating oxygen toxicity through antioxidants during anammox granular sludge preservation and mechanistic insights.

Bioresource technology·2026
Same author

Evolution of anammox granular sludge performance during long-term preservation: Insights from double exponential kinetics.

Bioresource technology·2026
Same author

Isomer-Resolved Real-Time Quantification and Dynamics of Indoor Carbonyl Compounds via NO<sup>+</sup> Chemical Ionization in PTR-MS.

Environmental science & technology·2026
Same author

Efficacy and safety of GS1-144, a novel neurokinin 3 receptor antagonist, for moderate-to-severe vasomotor symptoms associated with menopause in Chinese women: a randomized, double-blind, placebo-controlled phase 2 trial.

Menopause (New York, N.Y.)·2026
Same journal

Research advances and application prospects of CAR-T therapy in the treatment of age-related diseases.

Frontiers in immunology·2026
Same journal

Machine learning-driven identification and immunohistochemical validation of an integrated immune-inflammatory phenotype for disease-free survival stratification in breast cancer.

Frontiers in immunology·2026
Same journal

Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report.

Frontiers in immunology·2026
Same journal

Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma.

Frontiers in immunology·2026
Same journal

JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases.

Frontiers in immunology·2026
Same journal

Cross-talk among novel programmed cell death pathways: a decisive network in renal ischemia-reperfusion injury.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Oct 3, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.2K

Peptide-Based Vaccines for Tuberculosis.

Wenping Gong1, Chao Pan2, Peng Cheng1,3

  • 1Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8th Medical Center of PLA General Hospital, Beijing, China.

Frontiers in Immunology
|February 17, 2022
PubMed
Summary
This summary is machine-generated.

Developing new tuberculosis (TB) vaccines is crucial as the BCG vaccine is less effective in adults. Peptide-based vaccines show promise for improved TB prevention and control strategies.

Keywords:
adjuvantsanimal modelsbioinformaticsepitopeimmunitypeptide-based vaccinetuberculosis (TB)

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.8K

Related Experiment Videos

Last Updated: Oct 3, 2025

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

1.2K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.4K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

10.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a significant global health challenge, exacerbated by the COVID-19 pandemic, leading to increased mortality.
  • The current Bacillus Calmette-Guérin (BCG) vaccine offers limited efficacy in adults, highlighting the urgent need for more effective TB vaccines.

Purpose of the Study:

  • To review the current landscape of peptide-based vaccine development for tuberculosis.
  • To explore tools and strategies for designing effective peptide-based TB vaccines.
  • To discuss advancements in delivery systems and animal models for evaluating these vaccines.

Main Methods:

  • Review of current literature on peptide vaccines, immunoinformatics, bioinformatics, and synthetic technologies.
  • Analysis of research status and challenges in developing peptide-based TB vaccines.
  • Examination of protein-based delivery systems and animal models relevant to TB vaccine research.

Main Results:

  • Peptides and epitopes are critical for initiating adaptive immunity, making them promising vaccine components.
  • Innovations in various scientific fields are accelerating the development of peptide-based TB vaccines.
  • A comprehensive understanding of design tools, delivery systems, and animal models is essential for progress.

Conclusions:

  • Peptide-based vaccines offer a potential strategy for developing safer and more effective alternatives to BCG.
  • This review provides insights into approaches and strategies to advance TB vaccine development.
  • The findings aim to contribute to the World Health Organization's End TB Strategy.